PULMONARY HYPERTENSIVE CRISIS

PULMONARY HYPERTENSIVE CRISIS was reported 271 times

PULMONARY HYPERTENSIVE CRISIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline [EPC] 6 0.0064
1 Medium-chain Triglyceride [EPC] 1 0.0018
2 Prostacyclin Receptor Agonist [EPC] 29 0.0011
3 Phosphodiesterase 5 Inhibitor [EPC] 130 0.0010
4 Oxytocic [EPC] 2 0.0007
5 Prostacycline Vasodilator [EPC] 86 0.0006
6 Carnitine Analog [EPC] 2 0.0005
7 Endothelin Receptor Antagonist [EPC] 85 0.0004
8 Plasma Volume Expander [EPC] 1 0.0003
9 Penem Antibacterial [EPC] 11 0.0003
10 Catecholamine [EPC] 19 0.0002
11 Soluble Guanylate Cyclase Stimulator [EPC] 7 0.0002
12 Aldosterone Antagonist [EPC] 30 0.0002
13 Anticholinergic [EPC] 3 0.0002
14 General Anesthetic [EPC] 7 0.0002
15 Cardiac Glycoside [EPC] 11 0.0002
16 Glycopeptide Antibacterial [EPC] 10 0.0002
17 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2 0.0001
18 Vasopressin V2 Receptor Antagonist [EPC] 2 0.0001
19 Loop Diuretic [EPC] 45 0.0001
20 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
21 Provitamin D2 Compound [EPC] 2 0.0001
22 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
23 Angiotensin Converting Enzyme Inhibitor [EPC] 8 0.0001
24 Opioid Agonist [EPC] 14 0.0001
25 Cholinergic Muscarinic Antagonist [EPC] 2 0.0001
26 Human Immunoglobulin G [EPC] 1 0.0000
27 Antimetabolite Immunosuppressant [EPC] 1 0.0000
28 Protease Inhibitor [EPC] 2 0.0000
29 Osmotic Laxative [EPC] 13 0.0000
30 P2Y12 Platelet Inhibitor [EPC] 5 0.0000
31 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
32 Ester Local Anesthetic [EPC] 2 0.0000
33 Macrolide Antimicrobial [EPC] 2 0.0000
34 Histamine-2 Receptor Antagonist [EPC] 5 0.0000
35 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
36 Complement Inhibitor [EPC] 2 0.0000
37 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
38 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
39 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
40 Prostaglandin Analog [EPC] 3 0.0000
41 Benzodiazepine [EPC] 21 0.0000
42 Corticosteroid [EPC] 35 0.0000
43 Non-Standardized Chemical Allergen [EPC] 2 0.0000
44 Polyene Antifungal [EPC] 1 0.0000
45 Thiazide Diuretic [EPC] 5 0.0000
46 Amide Local Anesthetic [EPC] 2 0.0000
47 Aminoglycoside Antibacterial [EPC] 1 0.0000
48 Leukocyte Growth Factor [EPC] 3 0.0000
49 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
50 Antiarrhythmic [EPC] 2 0.0000
51 Azole Antifungal [EPC] 3 0.0000
52 Antirheumatic Agent [EPC] 2 0.0000
53 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
54 Methylxanthine [EPC] 1 0.0000
55 Fluoroquinolone Antibacterial [EPC] 2 0.0000
56 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
57 Nonsteroidal Anti-inflammatory Drug [EPC] 19 0.0000
58 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
59 Tetracycline-class Drug [EPC] 1 0.0000
60 Platelet Aggregation Inhibitor [EPC] 8 0.0000
61 Proton Pump Inhibitor [EPC] 8 0.0000
62 Vitamin D [EPC] 3 0.0000
63 Expectorant [EPC] 2 0.0000
64 Vitamin C [EPC] 4 0.0000
65 Vitamin B12 [EPC] 3 0.0000
66 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
67 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
68 Factor Xa Inhibitor [EPC] 2 0.0000
69 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
70 alpha-Adrenergic Blocker [EPC] 1 0.0000
71 beta-Adrenergic Blocker [EPC] 2 0.0000
72 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
73 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
74 Estrogen [EPC] 1 0.0000
75 Anti-epileptic Agent [EPC] 1 0.0000
76 Platinum-based Drug [EPC] 1 0.0000
77 Kinase Inhibitor [EPC] 2 0.0000
78 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
79 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
80 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
81 Insulin Analog [EPC] 1 0.0000
82 Atypical Antipsychotic [EPC] 1 0.0000
83 Tumor Necrosis Factor Blocker [EPC] 1 0.0000